<span style="display: block; margin-top: 60px;">Insulin lispro Sanofi<sup>®<span style="color: black;">▼</span></sup><span style="font-size: 0.6em; display: block; margin: 5px 0;">(Insulin lispro 100 units/mL)</span></span>
The first rapid acting insulin biosimilar of Humalog approved in the UK and EU1
25% lower NHS list price vs. Humalog cartridges and pre-filled pens and 15% lower NHS list price vs. Humalog vials2
1:1 initial unit dosing* – available in the SoloSTAR® pen, cartridges and vials3
*Changes in strength, brand, type, species and/or method of manufacture may result in the need for a change in dosage. Transferring to a different insulin should be done under strict medical supervision
Similar PK/PD profile (T1DM)6, efficacy, safety and tolerability profiles (T1DM and T2DM)4-5
Diabetes Stories
Learn from other payors, consultants and diabetes specialist nurses how they adopted a rapid acting insulin biosimilar in their region.
Dr Duncan Browne
Consultant Endocrinologist and Researcher Royal Cornwall Hospitals NHS Foundation Trust
Amanda<br/> Veall
Diabetes Specialist Nurse Cornwall Partnership NHS Foundation Trust
Marcus<br/> Jones
Formulary Pharmacist Gloucestershire Hospitals NHS Foundation Trust
Find useful resources such as formulary FAQ, leave pieces and videos for payors and healthcare professionals to support a positive rapid acting insulin biosimilar adoption
Abbreviations:
DSN, diabetes specialist nurse; EU, European Union, NHS, National Health Service; PD, pharmacodynamic; PK, pharmacokinetic; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; UK, United Kingdom.
References:
- European Commission. Community register of medicinal products for human use. Insulin lispro Sanofi. Available at: https://ec.europa.eu/health/documents/community-register/html/h1203.htm. Last accessed: November 2020
- British National Formulary Insulin lispro: solution for injection. Available at: https://bnf.nice.org.uk/medicinal-forms/insulin-lispro.html. Last accessed: November 2020
- Insulin lispro Sanofi SmPC, August 2020
- Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26
- Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.
- Kapitza C, et al. Diabetes Obes Metab. 2017;19(5):622–7.